Table 1 Correlations between circACVR2A expression levels and clinicopathological characteristics in BC
Characteristics | Â | circACVR2A expression | p | |
|---|---|---|---|---|
| Â | cases | Low (%) | High (%) | value |
Age(years) | Â | Â | Â | 0.557 |
 <  65 | 72(51.4) | 18(25) | 54(75) |  |
 ≥ 65 | 68(48.6) | 20(29.4) | 48(70.5) |  |
Gender | Â | Â | Â | 0.399 |
 Male | 103(73.6) | 26(25.2) | 77(74.8) |  |
 Female | 37(26.4) | 12(32.4) | 25(67.6) |  |
Pathology stage | Â | Â | Â | 0.016* |
 pTa-pT1 | 60(42.9) | 10(16.7) | 50(83.3) |  |
 pT2-pT4 | 80(57.1) | 28(35) | 52(65) |  |
Grade | Â | Â | Â | 0.038* |
 Low | 23(16.4) | 2(8.7%) | 21(91.3) |  |
 High | 117(83.6) | 36(30.8) | 81(69.2) |  |
Tumor size(cm) | Â | Â | Â | 0.591 |
 <  3 | 118(84.3) | 31(26.3) | 87(73.7) |  |
 ≥3 | 22(15.7) | 7(31.8%) | 15(68.2) |  |
Lymph nodes metastasis | Â | Â | Â | 0.036* |
 Negative | 109(77.9) | 25(22.9) | 84(77.1) |  |
 Positive | 31(22.1) | 13(41.9) | 18(58.1) |  |
Total | 140 | 38 | 102 | Â |